Valuation : Aprogen Biologics Inc.

Market Cap 24.07B 17.96M 15.48M 14.66M 13.29M 24.89M 1.71B 25.03M 174M 66.89M 871M 67.4M 65.93M 2.76B P/E 2024
-0.79x
P/E 2025 -0.6x
Enterprise Value 201B 150M 129M 123M 111M 208M 14.34B 209M 1.45B 559M 7.29B 563M 551M 23.1B EV / Sales 2024
3.66x
EV / Sales 2025 3.82x
Free-Float
42.08%
Yield 2024 *
-
Yield 2025 -
1 day+0.48%
1 week-7.24%
Current month-6.72%
1 month-22.09%
3 months-32.84%
6 months-59.88%
Current year-78.43%
1 week 1,616
Extreme 1616
1,940
1 month 1,616
Extreme 1616
2,455
Current year 1,616
Extreme 1616
8,490
1 year 1,616
Extreme 1616
9,945
3 years 1,616
Extreme 1616
67,500
5 years 1,616
Extreme 1616
204,750
10 years 1,616
Extreme 1616
858,000
Manager TitleAgeSince
Chief Executive Officer 63 2023-10-12
Chief Executive Officer 70 2012-03-31
Sales & Marketing 62 -
Director TitleAgeSince
Director/Board Member 70 2012-03-31
Director/Board Member 65 2020-03-22
Director/Board Member 63 2023-10-12
Date Insider Type Main position Quantity % Market Cap. Importance
6/28/24 Exercice

Executive/Senior Manager

6,183 0.0046%
6/28/24 Expiration

Chief Executive Officer

21,884 0.0164%
6/28/24 Exercice 11,846 0.0089% -
Change 5-day change 1-year change 3-year change Capi.($)
+0.48%-7.24%-82.99%-97.38% 17.96M
-0.65%-2.93%+47.70%+86.17% 994B
-0.29%-3.51%+49.15%+62.35% 640B
+0.83%+0.26%+17.76%+72.25% 454B
-0.38%-3.59%+30.13%+35.17% 337B
-0.09%-13.54%+13.34%+24.95% 261B
-0.43%-2.48%-2.07%+11.48% 246B
-1.34%-13.70%+36.53%+44.96% 204B
-3.44%-7.51%-20.08%-59.58% 190B
-0.75%-4.82%+25.46%+87.14% 178B
Average -0.61%-5.95%+11.49%+26.75% 350.48B
Weighted average by Cap. -0.51%-4.42%+30.89%+55.07%

Financials

2024 2025
Net sales 67.38B 50.26M 43.32M 41.03M 37.19M 69.67M 4.8B 70.07M 487M 187M 2.44B 189M 185M 7.74B 73.23B 54.63M 47.08M 44.59M 40.42M 75.72M 5.22B 76.16M 529M 203M 2.65B 205M 201M 8.41B
Net income -105B -78.31M -67.5M -63.93M -57.95M -109M -7.48B -109M -759M -292M -3.8B -294M -288M -12.05B -170B -127M -110M -104M -94.02M -176M -12.13B -177M -1.23B -473M -6.17B -477M -467M -19.56B
Net Debt 116B 86.31M 74.39M 70.46M 63.87M 120M 8.24B 120M 836M 322M 4.19B 324M 317M 13.28B 177B 132M 114M 108M 97.79M 183M 12.62B 184M 1.28B 492M 6.41B 496M 485M 20.34B
Logo Aprogen Biologics Inc.
Aprogen Biologics Inc, formerly Aprogen Pharmaceuticals Inc, is a Korea-based company principally engaged in the pharmaceutical business. The Company operates its business through two segments. The Medicine Business segment is engaged in the manufacture and sale of central nervous system drugs, autonomic agents, arteriosclerosis agents, metabolic agents, circulatory system drugs, biopharmaceuticals and others. The Segment is also engaged in the manufacture and sale of cosmetics such as skin moisturizers and others. The Gaming Business segment is engaged in the development and operation of role-playing games (RPGs).
Employees
262
Date Price Change Volume
26-09-11 ₩1,679.00 +0.48% 159,294
26-09-10 ₩1,671.00 +0.84% 173,795
26-09-09 ₩1,657.00 -2.87% 254,324
26-09-08 ₩1,706.00 -6.16% 468,312
26-09-07 ₩1,818.00 +0.44% 787,223
  1. Stock Market
  2. Stocks
  3. A003060 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!